ChemicalBook >> CAS DataBase List >>Axitinib-13C-d3
Axitinib-13C-d3
- CAS No.
- 1261432-00-1
- Chemical Name:
- Axitinib-13C-d3
- Synonyms
- Axitinib-13C-d3;[13C,2H3]-Axitinib;(E)-N-(methyl-13C-d3)-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
- CBNumber:
- CB94814349
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD32858131
- MOL File:
- Mol file
Last updated:2023-06-08 09:03:09
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302+H312+H332-H315-H319 | |||||||||
Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P501 | |||||||||
NFPA 704 |
|
Axitinib-13C-d3 price More Price(2)
Axitinib-13C-d3 Chemical Properties,Uses,Production
Description
Axitinib-13C-d3 is intended for use as an internal standard for the quantification of axitinib by GC- or LC-MS. Axitinib is a VEGFR inhibitor (IC50s = 1.2, 0.25, and 0.29 nM for VEGFR1, -2, and -3, respectively). It also inhibits c-Kit and PDGFRβ (IC50s = 1.7 and 1.6 nM, respectively). It inhibits VEGF-induced migration of and tube formation by human umbilical vein endothelial cells (HUVECs). Axitinib (1-100 mg/kg) reduces microvessel density, a marker of angiogenesis, and tumor growth in MV522 colon carcinoma, A375 melanoma, SN12C-GFP renal carcinoma, and U87 glioma mouse xenograft models in a dose-dependent manner. Formulations containing axitinib have been used in the treatment of renal cell carcinoma.
Axitinib-13C-d3 Preparation Products And Raw materials
Raw materials
Preparation Products
Axitinib-13C-d3 Suppliers
Global( 17)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | Mandy@hangyubiotech.com | China | 11013 | 58 |
Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 52927 | 58 |
ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11289 | 58 |
Nanjing Shizhou Biology Technology Co.,Ltd | 025-85560043 15850508050 | info@synzest.com | China | 9287 | 58 |
Manhag Testing Technology Co., Ltd | 020-020-3846236 17688849268 | 2443244976@qq.com | China | 7775 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | ORDERS@QCSRM.COM | China | 18820 | 58 |
Nanjing Shizhou Biology Technology Co.,Ltd | 18351873721 | helen.zhang@synzest.com | China | 8298 | 58 |
Shanghai Saikerui Biotechnology Co. , Ltd. | 021-58000709 15900491054 | info@scrbio.com | China | 9260 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 8740 | 58 |
guoyungurui | 18162595016 | 3287908757@qq.com | China | 10012 | 58 |
1261432-00-1(Axitinib-13C-d3)Related Search:
Axitinib Impurity c
Axitinib Impurity a
BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl-
Axitinib Impurity d
Axitinib Impurity 27
Axitinib Impurity 23
Axitinib Impurity 3
Axitinib Impurity 26
Axitinib Impurity 10
Axitinib Impurity 4
1of4
Axitinib-13C-d3
[13C,2H3]-Axitinib
(E)-N-(methyl-13C-d3)-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
1261432-00-1